SangStat encourages post-transplant compliance
This article was originally published in Clinica
SangStat unveiled CycloTech at the conference, a drug delivery system intended to help transplant patients keep up with their rigorous medication schedule. The compact hand-held device contains a built-in smart chip designed to deliver and track each dose of cyclosporin, the immunosuppressant which transplant patients must take every day to prevent organ rejection.
You may also be interested in...
The US is to ship only half of doses for Pfizer, Moderna COVID-19 vaccines in the first instance, while Rhizen Pharmaceuticals starts a Phase I trial of a DHODH inhibitor.
Given its ever-growing role as a critical component of the global biopharma industry, you can’t afford not to be up to speed on Asia. This biweekly selection of insights from our experienced on-the-ground team will help.
Becton Dickinson will spend $1.2bn over the next four years to improve its drug-delivery device manufacturing capabilities. See what Eric Borin, president of BD, said about it here.